Your browser doesn't support javascript.
loading
Protecting patients during a shortage of thrombolytic agents.
Ní Áinle, Fionnuala; Middeldorp, Saskia; Le Gal, Grégoire; Hunt, Beverley J.
Afiliação
  • Ní Áinle F; School of Medicine, University College Dublin, Dublin D07 AX57, Ireland; Department of Haematology, Mater Misericordiae University Hospital, Dublin, Ireland. Electronic address: fniainle@mater.ie.
  • Middeldorp S; Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Le Gal G; Department of Medicine, University of Ottawa, Ottawa, Canada.
  • Hunt BJ; Thrombosis and Haemophilia Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK; World Thrombosis Day Campaign, King's Healthcare Partners, London, UK.
Lancet ; 400(10359): 1193-1194, 2022 10 08.
Article em En | MEDLINE | ID: mdl-36216000
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrinolíticos / Infarto do Miocárdio Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrinolíticos / Infarto do Miocárdio Idioma: En Ano de publicação: 2022 Tipo de documento: Article